Saving lives, buying time : economics of malaria drugs in an age of resistance / Committee on the Economics of Antimalarial Drugs, Board on Global Health ; Kenneth J. Arrow, Claire Panosian, and Hellen Gelband, editors.

Format:

Book

Contributor:

Arrow, Kenneth Joseph, 1921-

Panosian, Claire.

Gelband, Hellen.

Institute of Medicine (U.S.). Committee on the Economics of Antimalarial Drugs.

Language:

English

Subjects (All):

Antimalarials--Economic aspects.

Antimalarials.

Pharmaceutical policy.

Drug resistance in microorganisms.

Malaria--drug therapy.

Antimalarials--therapeutic use.

Drug Costs.

Drug Resistance.

Medical Subjects:

Malaria--drug therapy.

Antimalarials--therapeutic use.

Drug Costs.

Drug Resistance.

Physical Description:

1 online resource (384 p.)

Edition:

1st ed.

Place of Publication:

Washington, D.C. : National Academies Press, c2004.

Language Note:

English

Summary:

For more than 50 years, low-cost antimalarial drugs silently saved millions of lives and cured billions of debilitating infections. Today, however, these drugs no longer work against the deadliest form of malaria that exists throughout the world. Malaria deaths in sub-Saharan Africa "currently just over one million per year "are rising because of increased resistance to the old, inexpensive drugs. Although effective new drugs called oeartemisinins are available, they are unaffordable for the majority of the affected population, even at a cost of one dollar per course. Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance examines the history of malaria treatments, provides an overview of the current drug crisis, and offers recommendations on maximizing access to and effectiveness of antimalarial drugs. The book finds that most people in endemic countries will not have access to currently effective combination treatments, which should include an artemisinin, without financing from the global community. Without funding for effective treatment, malaria mortality could double over the next 10 to 20 years and transmission will intensify.

Contents:

FrontMatter

Reviewers

Preface

Acknowledgments

Contents

Executive Summary

PART 1 A Response to the Current Crisis

1 Malaria Today

2 The Cost and Cost-Effectiveness of Antimalarial Drugs

3 The Case for a Global Subsidy of Antimalarial Drugs

4 An International System for Procuring Antimalarial Drugs

PART 2 Malaria Basics

5 A Brief History of Malaria

6 The Parasite, the Mosquito, and the Disease

7 The Human and Economic Burden of Malaria

8 Malaria Control

9 Antimalarial Drugs and Drug Resistance

PART 3 Advancing Toward Better Malaria Control

10 Research and Development for New Antimalarial Drugs

11 Maximizing the Effective Use of Antimalarial Drugs

Acronyms and Abbreviations

Glossary

Index.

Notes:

Bibliographic Level Mode of Issuance: Monograph

Includes bibliographical references and index.

ISBN:

9786610176120

9780309165938

0309165938

9781280176128

1280176121

9780309532334

0309532337

OCLC:

57743668